Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05079984 · ClinicalTrials.gov registry record · NA

Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain

A NA study of Chronic Pain and Adolescent Behavior, sponsored by Stanford University.

Active
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT05079984: Active NA study of Chronic Pain and Adolescent Behavior, sponsored by Stanford University.

NCT05079984 is a NA study of Chronic Pain and Adolescent Behavior that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 35 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05079984, a NA study of Chronic Pain and Adolescent Behavior, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This project proposes to systematically develop and evaluate the feasibility and preliminary effectiveness of a digitally delivered, graded exposure treatment for youth with chronic musculoskeletal pain, utilizing a sequential replicated and randomized single-case experimental design (SCED). SCED provides the opportunity to rigorously evaluate treatment effectiveness at the individual level. Development of iGET Living will be based on a series of short iterations, with alpha testing (Aim 1) on a small sample of adolescents with chronic pain (N = 15). For Aim 1, participants will participate in three, two hour focus groups (one per week over the course of three weeks), resulting in 6 total hours of participation per participant for Aim 1. Aim 2 will involve a sample (N = 20 youth) of naïve end-users. Participants will be enrolled in a baseline period ranging from 7-25 days (done to support SCED methodology) after which they will be enrolled in the online intervention program, lasting 6-weeks. Patients will be contacted 3-months post-discharge from treatment (week 22 of enrollment) and will complete self-report outcome measures at this time.

Primary Outcome

Participant-rated acceptability measured on 5-point Likert scale. Range 0-4 (higher scores indicate more acceptable). Questionnaire will be administered to youth with chronic pain and their parents.

Interventions

  • BEHAVIORAL Graded exposure treatment (GET)

Study Locations (1)

California

  • Pediatric Pain Management Clinic - Menlo Park

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2022-05-02
Est. Completion 2025-10-01
Phase NA
Stanford University

1,744 total trials

What the registry record for NCT05079984 still lists

NCT05079984 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower).

The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Graded exposure treatment (GET) is the first listed.

NCT05079984 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05079984 about?

NCT05079984 is a clinical study titled "Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain". This project proposes to systematically develop and evaluate the feasibility and preliminary effectiveness of a digitally delivered, graded exposure treatment for youth with chronic musculoskeletal pain, utilizing a sequential replicated and randomized single-case experimental design (SCED). SCED pr...

What is the current status of trial NCT05079984?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2022-05-02. Estimated completion is 2025-10-01.

What conditions does trial NCT05079984 study?

This clinical trial studies the following conditions: Chronic Pain, Adolescent Behavior, Child Behavior, Exposure.

What interventions are being tested in trial NCT05079984?

The interventions under investigation include: Graded exposure treatment (GET) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05079984?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05079984 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05079984's enrollment target sits among peer trials

35 231st of 301 higher than 68 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05079984, the US trial registry maintained by the National Library of Medicine. NCT05079984 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.